Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Kingworld Medicines Group stock

1110.HK
KYG5268M1006

Price

0.38
Today +/-
-0.00
Today %
-1.17 %
P

Kingworld Medicines Group stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Kingworld Medicines Group stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Kingworld Medicines Group stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Kingworld Medicines Group stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Kingworld Medicines Group's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Kingworld Medicines Group Stock Price History

DateKingworld Medicines Group Price
11/18/20240.38 undefined
11/15/20240.38 undefined
11/14/20240.38 undefined
11/13/20240.40 undefined
11/12/20240.43 undefined
11/11/20240.44 undefined
11/8/20240.45 undefined
11/7/20240.45 undefined
11/6/20240.45 undefined
11/5/20240.44 undefined
11/4/20240.45 undefined
11/1/20240.46 undefined
10/31/20240.45 undefined
10/30/20240.44 undefined
10/29/20240.45 undefined
10/28/20240.47 undefined
10/25/20240.47 undefined
10/24/20240.47 undefined
10/23/20240.48 undefined
10/22/20240.48 undefined
10/21/20240.49 undefined

Kingworld Medicines Group Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Kingworld Medicines Group, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Kingworld Medicines Group from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Kingworld Medicines Group’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Kingworld Medicines Group. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Kingworld Medicines Group’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Kingworld Medicines Group’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Kingworld Medicines Group’s growth potential.

Kingworld Medicines Group Revenue, EBIT and net profit per share

DateKingworld Medicines Group RevenueKingworld Medicines Group EBITKingworld Medicines Group Net Income
20231.08 B undefined78.68 M undefined38.1 M undefined
2022957.7 M undefined80.34 M undefined22.74 M undefined
2021847.39 M undefined71.24 M undefined30.32 M undefined
2020745.38 M undefined65.5 M undefined11.72 M undefined
2019977.93 M undefined69.03 M undefined43.43 M undefined
20181.08 B undefined63.3 M undefined41.01 M undefined
20171.03 B undefined62.67 M undefined51.06 M undefined
20161.05 B undefined99.17 M undefined46.97 M undefined
2015713.55 M undefined53.18 M undefined31.21 M undefined
2014660.32 M undefined49.53 M undefined37.87 M undefined
2013554.8 M undefined28.9 M undefined47.2 M undefined
2012626.8 M undefined48.1 M undefined48.5 M undefined
2011685.6 M undefined56 M undefined51 M undefined
2010638 M undefined48.9 M undefined42.9 M undefined
2009556.4 M undefined44.2 M undefined37.2 M undefined
2008536 M undefined47.9 M undefined34.4 M undefined
2007527.3 M undefined33.4 M undefined29.2 M undefined

Kingworld Medicines Group Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
20072008200920102011201220132014201520162017201820192020202120222023
0.530.540.560.640.690.630.550.660.711.051.031.080.980.750.850.961.08
-1.713.7314.757.37-8.61-11.5019.138.0347.69-2.094.56-9.37-23.7513.6912.9912.64
18.2224.0721.5821.9423.3623.4823.6523.6431.7030.6731.3328.8527.3337.5831.0528.9425.97
96129120140160147131156226323323311267280263277280
2934374251484737314651414311302238
-17.248.8213.5121.43-5.88-2.08-21.28-16.2248.3910.87-19.614.88-74.42172.73-26.6772.73
-----------------
-----------------
450450450467.1622.5623622.5625.06684.75650.81622.5622.5622.5614.41606.5606.72591.63
-----------------
Details

Keystats

ⓘ

Revenue and Growth

The Kingworld Medicines Group Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Kingworld Medicines Group is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (k)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (B)
20072008200920102011201220132014201520162017201820192020202120222023
                                 
48.431.283.6269.5141123.391.4230237.42322.41276.43175.8128.82261.46198.41256.17194.03
249.8250156.5205.4299.3271.5342.7356.9171.46289.56254.55294.03279.87246.19136.4772.987.26
24.76.64.86.64.996.815.675.6393.48103.0882.4988.9850.7143.63163.75147.54
99.198.675.959.349.121.339.97079.01127.63148.88182.06205.12130.22106.7484.76117.63
73112.6263.9142.934.749.441.8129.340.0254.835641.9131.2226.1754.4146.7542.16
495499584.7683.7529474.5522.6801.8603.53887.92838.94776.28734.01714.75639.66624.32588.62
4.43.53.64.418.964.679.980.190.8197.81149.68151.12177.64167.89209.94299.89385.72
045.4465568.6101.2127.6137.5180.43201174.58218.94237.19254.78259.84248.32272.62
00000000000000000
007.57.33.8000116.1797.3378.559.6740.8427.2713.70.130
0000000090.6990.6990.6990.6990.6990.6990.6990.6990.69
00000000018.990000000
4.448.957.166.791.3165.8207.5217.6478.1505.82493.46520.43546.36540.63574.17639.04749.03
0.50.550.640.750.620.640.731.021.081.391.331.31.281.261.211.261.34
                                 
00053.553.553.553.553.553.4753.4753.4753.4753.4753.4753.4753.4753.47
0089152.7152.7152.7152.7152.7152.7152.7152.7152.7152.7152.7152.7139.41139.41
43.229.867.177.9139.7197.8230.9249.9271.89296.23334.55357.15411.58404433.47451.91469.33
8989.1-0.186.348.118.415.4109.9107.8914.659.958-20.79-22.89-25.71-24.6-20.67
00000.50.5555.446.772.43-5.526.384.532.97-4.61-22.49
132.2118.9156370.4394.5422.9457.5571591.39523.82553.09565.79603.34591.8616.9615.58619.03
129111.4117.4134.1120.9111.3122.1157.2116.39237.45136.64169.08231.97123.78106.1138.79341.62
1.71.91.72.63.13.84.74.810.3110.418.58.887.226.7610.877.466.68
49.254.858.440.546.136.238.136.965.7752.96107.01118.59113.73120.57119.15116.21110.16
187.3159.6246.6197.847.259.998.4228.7167.56311.2412.98336.68214.33296.54229.92271.290
00000007.34.16114.91009.1287.588.01198.03
367.2327.7424.1375217.3211.2263.3434.9364.18726.92665.12633.23576.37555.65473.62541.74656.49
01006000003.300008.371.241.4511.39156.4
01.21.558.66.49.410.330.1828.1725.6425.2622.4319.9818.1215.4218.37
0000000000000006000
0101.261.558.66.49.413.630.1828.1725.6425.2630.8121.2119.5727.41174.77
367.2428.9485.6380225.9217.6272.7448.5394.37755.09690.76658.49607.18576.86493.2569.15831.25
0.50.550.640.750.620.640.731.020.991.281.241.221.211.171.111.181.45
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Kingworld Medicines Group provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Kingworld Medicines Group's financial health and stability.

Assets

Kingworld Medicines Group's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Kingworld Medicines Group must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Kingworld Medicines Group after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Kingworld Medicines Group's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
2007200820092010201120122013201420152016201720182019202020212022
35454658736163485189837069706967
010011112123252836343438
0000000000000000
-165-54108-38-12314-95-5145-123-31-2826-7-3071
6132-7-4-8-19-3-158-5-802579
9169842361414507000
587815171271526242419231422
-122515813-5368-49-5102-2726213212381186
-2-1-4-1-16-50-16-1-6-11-40-11-20-9-58-93
0303-14-8828-29-168-192417-7-2-50-84
25442-3845-27-161-8642912779
0000000000000000
517247-108-1501238235-61143-3-86-12581-7025
000237000000000-70-5
125-26-105172-52-30321440120-83-159-17425-87-51
73-50-15275117-228-7269-14-64-53-36-37-13-58
0-470-32-19-20-14-18-9-8-15-18-12-12-3-13
2-1752186-128-508108-67972-72-47137-6254
-124.54153.811.7-69.917.8-66.7-7.296.53-13.5932.2650.52112.42113.6622.8893.04
0000000000000000

Kingworld Medicines Group stock margins

The Kingworld Medicines Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Kingworld Medicines Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Kingworld Medicines Group.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Kingworld Medicines Group's sales revenue. A higher gross margin percentage indicates that the Kingworld Medicines Group retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Kingworld Medicines Group's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Kingworld Medicines Group's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Kingworld Medicines Group's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Kingworld Medicines Group. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Kingworld Medicines Group's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Kingworld Medicines Group Margin History

Kingworld Medicines Group Gross marginKingworld Medicines Group Profit marginKingworld Medicines Group EBIT marginKingworld Medicines Group Profit margin
202326.02 %7.29 %3.53 %
202228.99 %8.39 %2.37 %
202131.11 %8.41 %3.58 %
202037.59 %8.79 %1.57 %
201927.34 %7.06 %4.44 %
201828.87 %5.87 %3.8 %
201731.33 %6.08 %4.95 %
201630.71 %9.41 %4.46 %
201531.78 %7.45 %4.37 %
201423.67 %7.5 %5.73 %
201323.65 %5.21 %8.51 %
201223.47 %7.67 %7.74 %
201123.45 %8.17 %7.44 %
201021.96 %7.66 %6.72 %
200921.69 %7.94 %6.69 %
200824.14 %8.94 %6.42 %
200718.26 %6.33 %5.54 %

Kingworld Medicines Group Stock Sales Revenue, EBIT, Earnings per Share

The Kingworld Medicines Group earnings per share therefore indicates how much revenue Kingworld Medicines Group has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Kingworld Medicines Group earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Kingworld Medicines Group's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Kingworld Medicines Group’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Kingworld Medicines Group's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Kingworld Medicines Group Revenue, EBIT and net profit per share

DateKingworld Medicines Group Sales per ShareKingworld Medicines Group EBIT per shareKingworld Medicines Group Earnings per Share
20231.82 undefined0.13 undefined0.06 undefined
20221.58 undefined0.13 undefined0.04 undefined
20211.4 undefined0.12 undefined0.05 undefined
20201.21 undefined0.11 undefined0.02 undefined
20191.57 undefined0.11 undefined0.07 undefined
20181.73 undefined0.1 undefined0.07 undefined
20171.66 undefined0.1 undefined0.08 undefined
20161.62 undefined0.15 undefined0.07 undefined
20151.04 undefined0.08 undefined0.05 undefined
20141.06 undefined0.08 undefined0.06 undefined
20130.89 undefined0.05 undefined0.08 undefined
20121.01 undefined0.08 undefined0.08 undefined
20111.1 undefined0.09 undefined0.08 undefined
20101.37 undefined0.1 undefined0.09 undefined
20091.24 undefined0.1 undefined0.08 undefined
20081.19 undefined0.11 undefined0.08 undefined
20071.17 undefined0.07 undefined0.06 undefined

Kingworld Medicines Group business model

Kingworld Medicines Group is one of the most popular companies on Eulerpool.com.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Kingworld Medicines Group Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Kingworld Medicines Group historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Kingworld Medicines Group shares outstanding

The number of shares was Kingworld Medicines Group in 2023 — This indicates how many shares 591.627 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Kingworld Medicines Group earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Kingworld Medicines Group's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Kingworld Medicines Group’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Kingworld Medicines Group's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Kingworld Medicines Group dividend history and estimates

In 2023, Kingworld Medicines Group paid a dividend amounting to 0.02 CNY. Dividend means that Kingworld Medicines Group distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Kingworld Medicines Group provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Kingworld Medicines Group’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Kingworld Medicines Group's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Kingworld Medicines Group Dividend History

DateKingworld Medicines Group Dividend
20230.02 undefined
20220.02 undefined
20210.01 undefined
20200.02 undefined
20190.02 undefined
20180.03 undefined
20170.03 undefined
20160.02 undefined
20150.02 undefined
20140.04 undefined
20130.03 undefined
20120.04 undefined
20110.04 undefined

Kingworld Medicines Group dividend payout ratio

In 2023, Kingworld Medicines Group had a payout ratio of 66.49%. The payout ratio indicates the percentage of the company's profits that Kingworld Medicines Group distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Kingworld Medicines Group represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Kingworld Medicines Group could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Kingworld Medicines Group's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Kingworld Medicines Group Payout Ratio History

DateKingworld Medicines Group Payout ratio
202366.49 %
202263.77 %
202113 %
2020122.71 %
201932.25 %
201852.07 %
201735.97 %
201621.08 %
201540.48 %
201463.72 %
201336.25 %
201250.5 %
201146.38 %
201066.49 %
200966.49 %
200866.49 %
200766.49 %
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Kingworld Medicines Group.

Kingworld Medicines Group shareholders

%
Name
Stocks
Change
Date
54.05134 % Zhao (Li Sheng)320,228,25004/30/2024
15.22351 % Chan (Lok San)90,192,00004/30/2024
0.42265 % Zhou (Xuhua)2,504,00004/30/2024
0.01823 % Zhang (Jianbin)108,00004/30/2024
0.01215 % Wong (Cheuk Lam)72,00004/30/2024
0.01215 % Duan (Jidong)72,00004/30/2024
1

Kingworld Medicines Group Executives and Management Board

Mr. Li Sheng Zhao(63)
Kingworld Medicines Group Executive Chairman of the Board, Chief Executive Officer (since 2008)
Compensation 1.36 M
Ms. Lok San Chan(58)
Kingworld Medicines Group Executive Director (since 2008)
Compensation 1.21 M
Mr. Xuhua Zhou(55)
Kingworld Medicines Group General Manager of SZ Kingworld, Executive Director (since 2009)
Compensation 496,000
Mr. Jidong Duan(57)
Kingworld Medicines Group Independent Non-Executive Director
Compensation 274,000
Mr. Cheuk Lam Wong(53)
Kingworld Medicines Group Independent Non-Executive Director
Compensation 274,000
1
2
3
4
...
5

Kingworld Medicines Group Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Charmacy Pharmaceutical H Stock
Charmacy Pharmaceutical H
SupplierCustomer0,37-0,64-0,10-0,74-0,08-0,32
Sa Sa International Holdings Stock
Sa Sa International Holdings
SupplierCustomer0,070,750,740,920,830,29
Humana Stock
Humana
SupplierCustomer-0,10 0,43-0,20-0,13-0,18
Hong Kong Technology Venture Stock
Hong Kong Technology Venture
SupplierCustomer-0,210,780,040,600,750,44
JD com A Stock
JD com A
SupplierCustomer-0,390,750,150,670,66
Meituan B Stock
Meituan B
SupplierCustomer-0,40-0,32 0,840,820,57
AEON Stores Hong Kong Stock
AEON Stores Hong Kong
SupplierCustomer-0,48-0,190,220,760,750,52
Dairy Farm International Holdings Stock
Dairy Farm International Holdings
SupplierCustomer-0,59-0,180,660,640,740,67
Zhihu A Stock
Zhihu A
SupplierCustomer-0,740,64
Vipshop Holdings ADR Stock
Vipshop Holdings ADR
SupplierCustomer-0,77-0,680,010,350,650,45
1

Most common questions regarding Kingworld Medicines Group

What is the P/E ratio of Kingworld Medicines Group 2024?

The P/E ratio cannot be calculated for Kingworld Medicines Group at the moment.

What is the P/S ratio of Kingworld Medicines Group 2024?

The P/S cannot be calculated for Kingworld Medicines Group currently.

What is the Quality Investing of Kingworld Medicines Group?

The Quality Investing for Kingworld Medicines Group is 8/10.

What is the revenue of Kingworld Medicines Group 2024?

The revenue cannot currently be calculated for Kingworld Medicines Group.

How high is the profit of Kingworld Medicines Group 2024?

The profit cannot currently be calculated for Kingworld Medicines Group.

What is the business model of Kingworld Medicines Group

No history available for Kingworld Medicines Group.

What is the Kingworld Medicines Group dividend?

Kingworld Medicines Group pays a dividend of 0.02 CNY distributed over payouts per year.

How often does Kingworld Medicines Group pay dividends?

The dividend cannot currently be calculated for Kingworld Medicines Group or the company does not pay out a dividend.

What is the Kingworld Medicines Group ISIN?

The ISIN of Kingworld Medicines Group is KYG5268M1006.

What is the Kingworld Medicines Group ticker?

The ticker of Kingworld Medicines Group is 1110.HK.

How much dividend does Kingworld Medicines Group pay?

Over the past 12 months, Kingworld Medicines Group paid a dividend of 0.02 CNY . This corresponds to a dividend yield of about 6.56 %. For the coming 12 months, Kingworld Medicines Group is expected to pay a dividend of 0.02 CNY.

What is the dividend yield of Kingworld Medicines Group?

The current dividend yield of Kingworld Medicines Group is 6.56 %.

When does Kingworld Medicines Group pay dividends?

Kingworld Medicines Group pays a quarterly dividend. This is distributed in the months of July, June, July, July.

How secure is the dividend of Kingworld Medicines Group?

Kingworld Medicines Group paid dividends every year for the past 13 years.

What is the dividend of Kingworld Medicines Group?

For the upcoming 12 months, dividends amounting to 0.02 CNY are expected. This corresponds to a dividend yield of 6.56 %.

In which sector is Kingworld Medicines Group located?

Kingworld Medicines Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Kingworld Medicines Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Kingworld Medicines Group from 6/30/2024 amounting to 0.034 CNY, you needed to have the stock in your portfolio before the ex-date on 6/3/2024.

When did Kingworld Medicines Group pay the last dividend?

The last dividend was paid out on 6/30/2024.

What was the dividend of Kingworld Medicines Group in the year 2023?

In the year 2023, Kingworld Medicines Group distributed 0.024 CNY as dividends.

In which currency does Kingworld Medicines Group pay out the dividend?

The dividends of Kingworld Medicines Group are distributed in CNY.

All fundamentals about Kingworld Medicines Group

Our stock analysis for Kingworld Medicines Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kingworld Medicines Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.